Where I see patients (2)
My reviews
Selected research
-
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.
Molecular cancer therapeutics
-
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.
Cell reports. Medicine
-
Synthetic Lethal Targeting of Cyclin Dependent Kinase-12-Deficient Prostate Cancer with PARP Inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616
4.9